GSK PLANS $250 MILLION EQUITY INVESTMENT IN VIR BIOTECHNOLOGY

Highlights

• GSK and Vir Biotechnology will focus on making drugs and vaccines against COVID-19

• Vir Biotechnology will continue it’s partnership with other companies

• Shares of Vir Biotechnology rose by 30 percent on the Nasdaq

Pharm...